HLT Transcatheter Aortic Valve System for Aortic Valve Stenosis

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Baylor Scott & White The Heart Hospital Plano, Plano, TXAortic Valve StenosisHLT Transcatheter Aortic Valve System - Device
Eligibility
65+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing a new system for aortic valve replacement in people who are at high risk for the surgery. The goal is to see if it is safe and works well.

Treatment Effectiveness

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: Throughout the 5 year follow up period

1 day
Medical Devices
30 days
Primary Endpoint: Mortality at 30 days
Year 5
Secondary Safety Endpoint 3: Adverse Events
Month 60
Secondary Performance Endpoint 2: Post-procedural Valve Performance

Trial Safety

Trial Design

1 Treatment Group

HLT Transcatheter Aortic Valve System
1 of 1

Experimental Treatment

35 Total Participants · 1 Treatment Group

Primary Treatment: HLT Transcatheter Aortic Valve System · No Placebo Group · N/A

HLT Transcatheter Aortic Valve System
Device
Experimental Group · 1 Intervention: HLT Transcatheter Aortic Valve System · Intervention Types: Device
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
HLT Transcatheter Aortic Valve System
2014
N/A
~10

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: throughout the 5 year follow up period

Who is running the clinical trial?

HLT Inc.Lead Sponsor
5 Previous Clinical Trials
30 Total Patients Enrolled
4 Trials studying Aortic Valve Stenosis
20 Patients Enrolled for Aortic Valve Stenosis
Dean Kereiakes, MDPrincipal InvestigatorThe Christ Hospital
4 Previous Clinical Trials
3,247 Total Patients Enrolled
James Hermiller, MDPrincipal InvestigatorSt. Vincent Heart Center of Indian
3 Previous Clinical Trials
13,957 Total Patients Enrolled
Mathew Williams, MDPrincipal InvestigatorNYU Langone Medical Center
4 Previous Clinical Trials
426 Total Patients Enrolled
1 Trials studying Aortic Valve Stenosis
93 Patients Enrolled for Aortic Valve Stenosis

Eligibility Criteria

Age 65+ · All Participants · 6 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are considered frail if you have difficulty walking or performing basic daily activities, have a low body mass index, need a wheelchair or oxygen, have severe liver or lung disease, have had previous heart surgery, or have low levels of serum albumin.
You have certain health conditions or risk factors that make it dangerous for you to undergo surgical valve replacement. These include a hostile chest, a porcelain aorta, severe pulmonary hypertension, a history of chest radiation therapy, neuromuscular disease, or orthopedic disease. You must also be willing to attend follow-up appointments and give informed consent in writing.

Frequently Asked Questions

Are participants still being enrolled for this research study?

"As per the clinicaltrials.gov registry, this clinical trial is actively seeking subjects for testing. The listing of this medical experiment was first posted on April 27th 2017 and modified most recently on June 29th 2022." - Anonymous Online Contributor

Unverified Answer

How many healthcare facilities have initiated this research experiment?

"The Lindner Center for Research and Education at the Christ Hospital in Cincinnati, Ohio, Baylor Scott & White The Heart Hospital Plano in Plano, Texas, and NYU Langone Medical Center are among the multiple clinical trial sites running this medical study. Other 4 participating locations have also been identified." - Anonymous Online Contributor

Unverified Answer

How many participants are currently undergoing treatment in this clinical experiment?

"Correct. Clinicaltrials.gov confirms that this clinical study, which was first uploaded on April 27th 2017, is actively looking for participants. Approximately 35 patients across 4 different sites need to be enrolled in the trial." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.